Evaluation of human placental-based cellular, acellular and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPSTIM clinical trial. ijtr [Internet]. 2025 Oct. 30 [cited 2025 Nov. 5];1(Suppl 2). Available from: https://internationaljournaloftissuerepair.com/index.php/ijtr/article/view/34